That we will.
Your theory is as reasonably as any other. In fact my very first suspicion, was that the BOD wants a quick resolution and the opportunity to bank some money while MT wanted to take it further. Was there any mention of Pre Clinical work on other conditions in the Quarterly ? I cant be bothered checking at the moment.
No matter what shenanigans may be going on, ODD will make Pharmaust a very attractive proposition.
Just guessing everyone, so don't take these comments to seriously. But it would explain a host of curiosities.
That we will.Your theory is as reasonably as any other. In fact...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.28M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $139.5K | 688.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 115377 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 55779 | 3 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |